Key facts
- This page summarizes Robert Eugene Watson's Form 4 filing for CEL SCI CORP (CVM).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 14 Jun 2022, 17:30.
Robert Eugene Watson - 13 Jun 2022 Form 4 Insider Report for CEL SCI CORP (CVM)
- Role
- Director
- Signature
- Robert Watson
- Issuer symbol
- CVM
- Transactions as of
- 13 Jun 2022
- Net transactions value
- +$640
- Form type
- 4
- Filing time
- 14 Jun 2022, 17:30:44 UTC
- Previous filing
- 07 Jul 2021
- Next filing
- 10 Aug 2023
- SEC
- View on sec.gov
Key filing fact
Robert Eugene Watson filed Form 4 for CEL SCI CORP (CVM) on 14 Jun 2022.
Change
- Previous filing in this sequence was filed on 07 Jul 2021.
- Current net transaction value: +$640.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
CVM
transaction
Derivative
Options
Award
- Transaction value
- $640
- Shares
- +64,000
- Change %
- +13%
- Price
- $0.0100*
- Shares after
- 570,000
- Date
- 13 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 64,000
- Exercise price
- $3.35
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The stock options vest in three (3) equal annual installments commencing one year after the grant date. |